Questcor Provides Donation In Support Of Children's Hospital & Research Center Oakland

Questcor Provides Donation In Support Of Children's Hospital & Research Center

PR Newswire

HAYWARD, Calif., Dec. 17, 2013

HAYWARD, Calif., Dec. 17, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
(NASDAQ: QCOR) today announced that it has made a $25,000 donation to the
Children's Hospital & Research Center Oakland in support of the Early
Intervention Services program.

Children's Hospital & Research Center Oakland is a premier, not-for-profit
medical center for children in Northern California, and is the only hospital
in the East Bay that is 100% devoted to pediatrics. Their Early Intervention
Services program supports the well-being, development and caregiving
relationships of infants and young children (up to age 6) who have
developmental, social-emotional and medically related vulnerabilities or

"Questcor is committed to giving back to our local community," said Steve
Cartt, Chief Operating Officer for Questcor. "We feel privileged to be able to
support such a worthy institution, particularly one that is funded solely by
grants and charitable contributions. Our hope is that these funds will help
improve the quality of life for some Bay Area children who are in need."

In addition to the financial contribution, Mr. Cartt noted that Questcor
employees in Hayward created get well cards for children being treated at the
hospital. These cards are distributed to children on their lunch trays. "In
addition to the donation, we wanted to find a way to more personally connect
with the children and their families, especially during the holiday season,"
Mr. Cartt said. "This seemed to be a great way to do it."

Susan Greenwald, Director of Early Intervention Services, shared, "We're
grateful for Questcor's generous donation and look forward to putting the
money to good use serving children and families. We also appreciate the time
and effort Questcor employees gave to produce beautiful get-well cards. I
know they will help lift the spirits of our courageous young patients."

About Children's Hospital & Research Center
Children's Hospital & Research Center Oakland is a national leader in many
pediatric specialties including hematology/oncology, neonatology, cardiology,
orthopaedics, sports medicine, and neurosurgery. The hospital is one of only
two solely designated California Level 1 pediatric trauma centers in the
region, and has one of largest pediatric intensive care units in Northern
California. Children's is also a leading teaching hospital with an
outstanding pediatric residency program and a number of unique pediatric
subspecialty fellowship programs.

Children's research arm, Children's Hospital Oakland Research Institute is
internationally known for its basic and clinical research. CHORI is at the
forefront of translating research into interventions for treating and
preventing human diseases.

Each year, more than 75,000 children from the San Francisco Bay Area and the
country receive care. No child is turned away because of a family's inability
to pay. For more information, please visit

About Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune and
inflammatory disorders. Questcor's specific areas of focus are in the fields
of neurology, nephrology and rheumatology, and the company is currently
supporting research efforts in a variety of conditions having significant
unmet medical need. For more information about Questcor, please visit

SOURCE Questcor Pharmaceuticals, Inc.

Contact: Mark Leonard, 847-651-9682,, or Melinda
Krigel, 510-428-3069,
Press spacebar to pause and continue. Press esc to stop.